BOTULINUM TOXIN THERAPY IN THE CONTEXT OF MODERN TREATMENT STRATEGIES FOR TIC DISORDERS IN CHILDREN
Keywords:
tic disorders, children, botulinum toxin type A, botulinum therapy, hyperkinesia, YGTSS, focal tics.Abstract
Tic disorders represent a common form of hyperkinetic movement disorders in children and are often associated with significant functional and psycho-emotional impairments. The aim of the study was to evaluate the efficacy and safety of botulinum toxin type A in the treatment of focal tics in children. The analysis demonstrated that local botulinum toxin injections were associated with a significant reduction in tic severity according to the Yale Global Tic Severity Scale (YGTSS), with the maximum therapeutic effect observed between days 10 and 20 after injection. Most patients showed clinically significant improvement in hyperkinetic symptoms with a favorable safety and tolerability profile. The obtained results support the feasibility of including botulinum toxin type A in the комплекс treatment of focal tic disorders in children.
References
Зыков В.П. Тики и синдром Туретта у детей. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(5):116 124. https://doi.org/10.17116/jnevro2020120051116
Singer, Harvey S., et al. Movement disorders in childhood. Academic press, 2015.
Заваденко Н.Н., Доронина О.Б., Нестеровский Ю.Е. Хронические тики и синдром Туретта у детей и подростков: особенности диагностики и лечения. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(1):102 109. https://doi.org/10.17116/jnevro201511511102-109
Ueda K, Black KJ. A Comprehensive Review of Tic Disorders in Children. J Clin Med. 2021;10(11):2479. https://doi.org/10.3390/jcm10112479
Bloch M.H., Leckman J.F. Clinical course of Tourette syndrome. J. Psychosom. Res. 2009;67:497–501. https://doi.org/10.1016/j.jpsychores.2009.09.002.
Black KJ, Kim S, Yang NY, Greene DJ. Course of tic disorders over the lifespan. Curr Dev Disord Rep. 2021;8(2):121-132. https://doi.org/10.1007/s40474-021-00231-3
